Bioanalysis considerations on the pharmacokinetic evaluation of antisense therapeutics
Daniel A Norris1, Noah Post1, Rosie Z Yu1
1Ionis Pharmaceuticals, 2855 Gazelle Court, Carlsbad, CA 92010, USA.
No abstract available in PubMed .
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Study Design: Single Versus Multiple Dose Studies
Biopharmaceutics and Pharmacokinetics: Overview
Measurement of Bioavailability: Pharmacokinetic Methods
Bioavailability: Influencing Factors
